Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Thompson

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
BMJ Open|September 9, 2017
Effect of time and day of admission on hospital care quality for patients with chronic obstructive pulmonary disease exacerbation in England and Wales: single cohort studyChristopher Michael Roberts, Derek Lowe, Emma Skipper, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2013
Virological self-sampling to monitor influenza antiviral susceptibility in a community cohortAngie Lackenby, Alex J Elliot, Cassandra Powers, et al.
Frontiers in Immunology|February 16, 2018
Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine EfficacyHelen T Groves, Jacqueline U McDonald, Pinky Langat, et al.
Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.
European Urology|April 11, 2022
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)Michael Kennelly, Francisco Cruz, Sender Herschorn, et al.
Neurourology and Urodynamics|November 2, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)Pierre Denys, Juan Carlos Castaño Botero, Ricardo Luis Vita Nunes, et al.
Human Mutation|August 21, 2012
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 14, 2016
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2016
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
BMJ Open|September 9, 2017
Effect of time and day of admission on hospital care quality for patients with chronic obstructive pulmonary disease exacerbation in England and Wales: single cohort studyChristopher Michael Roberts, Derek Lowe, Emma Skipper, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2013
Virological self-sampling to monitor influenza antiviral susceptibility in a community cohortAngie Lackenby, Alex J Elliot, Cassandra Powers, et al.
Frontiers in Immunology|February 16, 2018
Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine EfficacyHelen T Groves, Jacqueline U McDonald, Pinky Langat, et al.
Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.
European Urology|April 11, 2022
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)Michael Kennelly, Francisco Cruz, Sender Herschorn, et al.
Neurourology and Urodynamics|November 2, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)Pierre Denys, Juan Carlos Castaño Botero, Ricardo Luis Vita Nunes, et al.
Human Mutation|August 21, 2012
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 14, 2016
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2016
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Pageof 8